Forecast: Insulin in Dosage Market Size Value Per Capita in Sweden

The insulin dosage market size value per capita in Sweden is forecasted to decline incrementally over the next five years. From 2024 to 2028, the value in US Dollars per capita is expected to decrease from 18.91 to 17.15. In contrast, the value in 2023 stood at 19.5. Year-on-year variations indicate a consistent decrease, with declines of approximately 2.7% from 2024 to 2025, 2.6% from 2025 to 2026, 2.3% from 2026 to 2027, and 2.1% from 2027 to 2028. The compound annual growth rate (CAGR) over this five-year period is roughly -2.3%.

Future trends to watch for include potential advancements in insulin delivery technologies, shifts in healthcare policy, and the increasing prevalence of diabetes, which may counterbalance the current downward trend in per capita spending. Moreover, any significant changes in pricing strategies by insulin manufacturers could also impact market dynamics.